Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 933 blog entries.

June 2025

PathAI and Northwestern Medicine Announce Strategic Collaboration to Deploy the AISight® Digital Pathology Platform and Co-Develop New AI Diagnostics

2025-06-09T08:48:42+00:00

Collaboration includes use of PathAI’s AISight®¹ digital pathology image management system at Northwestern Medicine and joint efforts in research, clinical innovation, and algorithm co-development to advance pathology-based diagnostics. PathAI, a leading provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago’s premier integrated academic health system, today announced a strategic collaboration to transform pathology diagnostics through [...]

PathAI and Northwestern Medicine Announce Strategic Collaboration to Deploy the AISight® Digital Pathology Platform and Co-Develop New AI Diagnostics2025-06-09T08:48:42+00:00

Illumina Expands Clinical Oncology Portfolio Unlocking New Standard of Care and Access to Precision Therapies

2025-06-02T12:49:19+00:00

Following FDA approval last year, Illumina's TSO Comprehensive test gains broad payer reimbursement, expanding access to comprehensive genomic profiling to match patients with targeted therapies Illumina's IVD portfolio will also expand to offer Pillar oncoReveal® CDx, the newest panel to deliver critical companion diagnostic testing using the Illumina MiSeq™ Dx System Illumina Inc. today announced an [...]

Illumina Expands Clinical Oncology Portfolio Unlocking New Standard of Care and Access to Precision Therapies2025-06-02T12:49:19+00:00

Case of the Month | June 2025 | Case of a Trichoblastoma in a 7-year-old Labrador

2025-07-16T10:05:36+00:00

Author: Stacey Newton BVSc FRCPath CertEM (Int Med) PhD MRCVS A 7-year-old male neutered Labrador presented with a 2 cm raised firm mass present at the base of the right ear. It appeared not to be attached underneath and was quite mobile. Fine-needle aspirates for cytology were performed. Cytology: This demonstrated mainly several varying sized [...]

Case of the Month | June 2025 | Case of a Trichoblastoma in a 7-year-old Labrador2025-07-16T10:05:36+00:00

Austria’s Tyrolpath Leads Europe with First Clinical Adoption of Techcyte SureView™

2025-08-11T07:09:11+00:00

Techcyte, leader in AI-powered digital pathology, announced today the first European clinical implementation of its Techcyte SureView™ cervical cytology solution at Tyrolpath, one of the largest private pathology laboratories in Austria. In partnership with BD, Techcyte’s exclusive global distributor for Techcyte SureView™, this milestone marks a significant advancement in the digital transformation of cervical cancer screening in [...]

Austria’s Tyrolpath Leads Europe with First Clinical Adoption of Techcyte SureView™2025-08-11T07:09:11+00:00

May 2025

Empowering Pathologists with AI: Mindpeak & AstraZeneca Present Breakthrough HER2 Research at ASCO 2025

2025-06-05T11:39:32+00:00

Mindpeak is honored to present their joint research with AstraZeneca on AI-assisted training for HER2 IHC interpretation at the 2025 ASCO Annual Meeting - delivered today, Friday, May 30th , by Marina de Brot in Hall D2 . Why it matters: The classification of HER2-low and the emerging HER2-ultralow breast cancer category is becoming increasingly important [...]

Empowering Pathologists with AI: Mindpeak & AstraZeneca Present Breakthrough HER2 Research at ASCO 20252025-06-05T11:39:32+00:00

Precision at the Point of Diagnosis: The Role of Genomic Tests in Personalized Pathology

2025-06-04T10:24:30+00:00

Welcome to PathPulse, the Digital Diagnostic podcast! In this episode, “Precision at the Point of Diagnosis: The Role of Genomic Tests in Personalized Pathology,” host James Thackeray is joined by Jay Jhaveri to explore the transformative impact of genomic testing on modern diagnostics. Jay Jhaveri is the Senior Director at Pacific Edge Cancer Diagnostics. His extensive [...]

Precision at the Point of Diagnosis: The Role of Genomic Tests in Personalized Pathology2025-06-04T10:24:30+00:00

Aiforia Appoints Richard Doughty as Medical Director

2025-06-03T11:46:30+00:00

Aiforia Technologies has appointed pathologist Richard Doughty (MD, DVM, MSc) as the Medical Director of the company. With this new position, Aiforia aims to strengthen its leadership with enhanced medical expertise. Richard Doughty is a medical doctor and specialist in pathology with extensive diagnostic experience. Additionally, he is a qualified veterinarian with pathology expertise in pharmaceutical research and development. [...]

Aiforia Appoints Richard Doughty as Medical Director2025-06-03T11:46:30+00:00

Lumea Enhances Digital Pathology Platform with AI-Powered Urine Cytology Solution Through AIxMed Partnership

2025-06-03T08:13:21+00:00

Lumea and AIxMed team up to bring AI-driven urine cytology to Lumea’s platform, targeting improved bladder cancer diagnostics. Lumea, a leading provider of primary clinical digital pathology solutions, today announced a new partnership with AIxMed, an innovator in AI diagnostics for urine cytology. This collaboration will integrate AIxMed’s specialized AI technology into Lumea’s FDA-cleared digital pathology [...]

Lumea Enhances Digital Pathology Platform with AI-Powered Urine Cytology Solution Through AIxMed Partnership2025-06-03T08:13:21+00:00

Pathology in the Cloud: Why a Cloud-based Archive Makes Sense for Your Digital Pathology Solution

2025-09-12T13:58:42+00:00

When Hospital Clínic de Barcelona initiated a project to digitize its pathology department, it anticipated greater efficiency, more convenient access to studies and easier collaboration among care team members. It also foresaw a significant challenge: managing the large volumes of information generated by a digital pathology system. The hospital’s anatomical pathology service performs more than 50,000 [...]

Pathology in the Cloud: Why a Cloud-based Archive Makes Sense for Your Digital Pathology Solution2025-09-12T13:58:42+00:00

Illumina Comprehensive Genomic Profiling Test for Cancer Receives Regulatory Approval in Japan

2025-06-02T12:48:59+00:00

TruSight™ Oncology Comprehensive for cancer genomic profiling is expected to expand access to precision oncology options for patients in Japan Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced today that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) for TruSightTM Oncology (TSO) Comprehensive for Class III/IV Medical [...]

Illumina Comprehensive Genomic Profiling Test for Cancer Receives Regulatory Approval in Japan2025-06-02T12:48:59+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top